histamine has been researched along with tcv 309 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naraba, H; Oh-ishi, S; Tokumasu, T; Ueno, A | 1 |
| Egashira, K; Fukumoto, Y; Kadokami, T; Katsumata, N; Kozai, T; Kuwata, K; Shimokawa, H; Takeshita, A; Yamawaki, T | 1 |
2 other study(ies) available for histamine and tcv 309
| Article | Year |
|---|---|
The mediators involved in endotoxin-induced vascular permeability increase in the rat skin and their interactions.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Bradykinin Receptor Antagonists; Capillary Permeability; Dose-Response Relationship, Drug; Drug Synergism; Escherichia coli; Extravasation of Diagnostic and Therapeutic Materials; Histamine; Histamine H1 Antagonists; Indomethacin; Isoquinolines; Lipopolysaccharides; Male; Methysergide; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pyridinium Compounds; Pyrilamine; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Skin; Specific Pathogen-Free Organisms; Tetrahydroisoquinolines | 1996 |
Platelet activating factor causes hyperconstriction at the inflammatory coronary lesions in pigs in vivo.
Topics: Animals; Coronary Vasospasm; Coronary Vessels; Dinoprost; Drug Synergism; Histamine; Interleukin-1; Isoquinolines; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Protein Kinase C; Pyridinium Compounds; Serotonin; Swine; Tetrahydroisoquinolines; Vasoconstriction | 1997 |